NO20090541L - Prodrug av cinnamidforbindelse - Google Patents
Prodrug av cinnamidforbindelseInfo
- Publication number
- NO20090541L NO20090541L NO20090541A NO20090541A NO20090541L NO 20090541 L NO20090541 L NO 20090541L NO 20090541 A NO20090541 A NO 20090541A NO 20090541 A NO20090541 A NO 20090541A NO 20090541 L NO20090541 L NO 20090541L
- Authority
- NO
- Norway
- Prior art keywords
- prodrug
- cinnamide compound
- formula
- group
- cinnamide
- Prior art date
Links
- -1 cinnamide compound Chemical class 0.000 title abstract 3
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 229910052731 fluorine Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Cultivation Of Plants (AREA)
- Seasonings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82076106P | 2006-07-28 | 2006-07-28 | |
| JP2006206007 | 2006-07-28 | ||
| US86925906P | 2006-12-08 | 2006-12-08 | |
| JP2006331274 | 2006-12-08 | ||
| PCT/JP2007/064637 WO2008013213A1 (fr) | 2006-07-28 | 2007-07-26 | Promédicament d'un composé cinnamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090541L true NO20090541L (no) | 2009-02-03 |
Family
ID=38981524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090541A NO20090541L (no) | 2006-07-28 | 2009-02-03 | Prodrug av cinnamidforbindelse |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7737141B2 (fr) |
| EP (1) | EP2048143A4 (fr) |
| JP (1) | JPWO2008013213A1 (fr) |
| KR (1) | KR20090033910A (fr) |
| AR (1) | AR062095A1 (fr) |
| AU (1) | AU2007277729A1 (fr) |
| CA (1) | CA2658037A1 (fr) |
| CO (1) | CO6150153A2 (fr) |
| CR (1) | CR10499A (fr) |
| EA (1) | EA200970172A1 (fr) |
| EC (1) | ECSP099091A (fr) |
| GE (1) | GEP20115176B (fr) |
| HN (1) | HN2009000157A (fr) |
| IL (1) | IL196351A0 (fr) |
| MA (1) | MA30636B1 (fr) |
| MX (1) | MX2008015504A (fr) |
| MY (1) | MY144971A (fr) |
| NO (1) | NO20090541L (fr) |
| NZ (1) | NZ574102A (fr) |
| PE (1) | PE20080281A1 (fr) |
| SA (1) | SA07280403B1 (fr) |
| SV (1) | SV2009003157A (fr) |
| TN (1) | TN2009000024A1 (fr) |
| TW (1) | TW200821319A (fr) |
| WO (1) | WO2008013213A1 (fr) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2261218B1 (fr) * | 2004-05-26 | 2013-04-03 | Eisai R&D Management Co., Ltd. | Imidazolverbindung zur Verwendung als Intermediat in der Herstellung von Cinnamid-Verbindungen |
| KR20070083781A (ko) * | 2004-10-26 | 2007-08-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물의 비정질체 |
| CA2628047A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Procede de production d'un derive cinnamide |
| EP1953151A4 (fr) * | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | Sels de composé cynamide ou solvates de ces derniers |
| TWI386207B (zh) * | 2005-11-24 | 2013-02-21 | Eisai R&D Man Co Ltd | 味啉類型之肉桂醯胺化合物 |
| TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| SA07280403B1 (ar) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
| TW200848054A (en) * | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
| CN101679360A (zh) * | 2007-05-16 | 2010-03-24 | 卫材R&D管理有限公司 | 一步生产肉桂酰胺衍生物的方法 |
| US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| AR068121A1 (es) | 2007-08-31 | 2009-11-04 | Eisai R&D Man Co Ltd | Compuestos multiciclicos para tratar enfermedades neurodegenerativas |
| WO2009086277A1 (fr) | 2007-12-20 | 2009-07-09 | Envivo Pharmaceuticals, Inc. | Benzènes tétrasubstitués |
| KR101204213B1 (ko) | 2007-12-21 | 2012-11-26 | 에프. 호프만-라 로슈 아게 | 오렉신 수용체 길항제로서의 헤테로아릴 유도체 |
| ATE535515T1 (de) | 2008-01-11 | 2011-12-15 | Hoffmann La Roche | Modulatoren für amyloid beta |
| CA2712095A1 (fr) * | 2008-01-28 | 2009-08-06 | Eisai R&D Management Co., Ltd. | Composes cristallins de cinnamide ou sels de ceux-ci |
| KR101247840B1 (ko) | 2008-02-22 | 2013-03-26 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타 조절제 |
| JP5502089B2 (ja) | 2008-10-09 | 2014-05-28 | エフ．ホフマン−ラ ロシュ アーゲー | アミロイドβのモジュレーター |
| CN102209537A (zh) | 2008-11-10 | 2011-10-05 | 弗·哈夫曼-拉罗切有限公司 | 杂环γ分泌酶调节剂 |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| WO2012002773A2 (fr) * | 2010-07-02 | 2012-01-05 | Bio-Pharm Solutions Co., Ltd. | Composé de phénylcarbamate et relaxant musculaire le contenant |
| CN103282346B (zh) | 2011-01-13 | 2014-11-19 | 比皮艾思药物研发有限公司 | 用于制备苯基氨基甲酸酯衍生物的方法 |
| RU2014100963A (ru) | 2011-06-15 | 2015-07-20 | Басф Се | Разветвленные сложные полиэфиры с сульфонатными группами |
| US8901066B2 (en) | 2011-06-15 | 2014-12-02 | Basf Se | Branched polyesters with sulfonate groups |
| RU2632659C2 (ru) * | 2011-12-27 | 2017-10-09 | Байо-Фарм Солюшнс Ко., Лтд. | Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии |
| WO2014142547A1 (fr) * | 2013-03-12 | 2014-09-18 | Bio-Pharm Solutions Co., Ltd. | Composé carbamate de phényle et composition pour une neuroprotection le comprenant |
| JP6062077B2 (ja) | 2013-03-12 | 2017-01-18 | バイオ−ファーム ソリューションズ カンパニー リミテッド | 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝ |
| LT3552017T (lt) * | 2016-12-09 | 2022-05-10 | Denali Therapeutics Inc. | Junginiai, naudotini kaip ripk1 inhibitoriai |
| CN110143935B (zh) * | 2019-06-03 | 2022-09-30 | 华侨大学 | 一种2，5-二取代呋喃衍生物的制备方法 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3689506D1 (de) * | 1985-10-09 | 1994-02-17 | Shell Int Research | Neue Acrylsäureamide. |
| DE3541716A1 (de) | 1985-11-26 | 1987-05-27 | Celamerck Gmbh & Co Kg | Neue acrylsaeureamide |
| JPH03206042A (ja) | 1990-01-06 | 1991-09-09 | Takeda Chem Ind Ltd | 降圧剤 |
| DE69126251T2 (de) * | 1990-02-08 | 1997-09-25 | Eisai Co Ltd | Benzensulfonamidderivat |
| JPH05194517A (ja) | 1992-01-16 | 1993-08-03 | Tanabe Seiyaku Co Ltd | ６−メルカプトプリン誘導体及びその製法 |
| AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| AU3577995A (en) | 1994-10-04 | 1996-04-26 | Fujisawa Pharmaceutical Co., Ltd. | Urea derivatives and their use as acat-inhibitors |
| JPH08283219A (ja) | 1995-04-07 | 1996-10-29 | Eisai Co Ltd | アラルキルアミノアルキルアミド誘導体 |
| ATE215950T1 (de) * | 1996-05-10 | 2002-04-15 | Icos Corp | Carbolinderivate |
| BR9710752A (pt) | 1996-07-22 | 1999-08-17 | Monsanto Co | Inbidores de metaloprotease de sulfonamida de tiol |
| JP2001508767A (ja) | 1996-12-02 | 2001-07-03 | 藤沢薬品工業株式会社 | ５―ｈｔ拮抗作用を有するインドール―ウレア誘導体 |
| RU2189982C2 (ru) | 1997-03-31 | 2002-09-27 | Такеда Кемикал Индастриз, Лтд. | Азольные соединения, способ их получения, противогрибковая фармацевтическая композиция и способ лечения грибковой инфекции |
| JP3108997B2 (ja) | 1997-03-31 | 2000-11-13 | 武田薬品工業株式会社 | アゾール化合物、その製造法および用途 |
| AU754965B2 (en) | 1997-12-31 | 2002-11-28 | University Of Kansas, The | Water soluble prodrugs of tertiary amine containing drugs and methods of making thereof |
| GB9816984D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Plc | Novel compounds |
| US6235728B1 (en) * | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
| CN1348442A (zh) | 1999-02-26 | 2002-05-08 | 默克公司 | 新的磺胺化合物及其应用 |
| AU2899400A (en) * | 1999-03-04 | 2000-09-21 | Nortran Pharmaceuticals Inc. | Aminocycloalkyl cinnamide compounds for arrhythmia and as analgesics and anesthetics |
| US20040087798A1 (en) * | 2000-03-14 | 2004-05-06 | Akira Yamada | Novel amide compounds |
| US20010051642A1 (en) * | 2000-04-17 | 2001-12-13 | Kyunghye Ahn | Method for treating Alzheimer's disease |
| AU2001254555A1 (en) | 2000-04-24 | 2001-11-07 | Merck Frosst Canada & Co | Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore |
| NZ525917A (en) * | 2000-12-04 | 2005-11-25 | F | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists and their use in treating mGLuR5 receptor mediated disorders |
| GB0108770D0 (en) * | 2001-04-06 | 2001-05-30 | Eisai London Res Lab Ltd | Inhibitors |
| MXPA04005427A (es) * | 2001-12-10 | 2005-04-19 | Amgen Inc | Ligandos de receptor vainilloide y su uso en tratamientos. |
| DK1465861T3 (da) * | 2001-12-20 | 2009-08-31 | Bristol Myers Squibb Co | Alpha-(N-sulfonamid)acetamidderivater som beta-amyloidhæmmere |
| JP2003206280A (ja) | 2001-12-28 | 2003-07-22 | Takeda Chem Ind Ltd | ビアリール化合物およびその用途 |
| DE10211101A1 (de) | 2002-03-14 | 2003-09-25 | Basf Ag | Katalysatoren und Verfahren zur Herstellung von Aminen |
| GB0207436D0 (en) | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| JP2005531574A (ja) * | 2002-05-22 | 2005-10-20 | アムジエン・インコーポレーテツド | 痛みの治療にバニロイド受容体リガンドとして使用するためのアミノ−ピリジン、−ピリジンおよびピリダジン誘導体 |
| PT1511710E (pt) | 2002-05-31 | 2014-02-26 | Proteotech Inc | Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson |
| AU2003249937A1 (en) | 2002-07-12 | 2004-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| US6900354B2 (en) * | 2002-07-15 | 2005-05-31 | Hoffman-La Roche Inc. | 3-phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
| AU2004210711B2 (en) * | 2003-02-12 | 2010-07-08 | Transtech Pharma, Inc. | Substituted azole derivatives as therapeutic agents |
| CN102584813B (zh) | 2003-05-14 | 2016-07-06 | Ngc药物公司 | 化合物及其在调节淀粉样蛋白β中的用途 |
| WO2005020921A2 (fr) | 2003-08-29 | 2005-03-10 | Exelixis, Inc. | Modulateurs c-kit et leurs procedes d'utilisation |
| AP2331A (en) | 2003-12-22 | 2011-12-05 | Pfizer | Triazole derivatives as vasopressin antagonists. |
| WO2005080346A1 (fr) * | 2004-02-12 | 2005-09-01 | Transtech Pharma, Inc. | Derives d'azole substitues, compositions, et procedes d'utilisation |
| EP2261218B1 (fr) * | 2004-05-26 | 2013-04-03 | Eisai R&D Management Co., Ltd. | Imidazolverbindung zur Verwendung als Intermediat in der Herstellung von Cinnamid-Verbindungen |
| KR20070083781A (ko) * | 2004-10-26 | 2007-08-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물의 비정질체 |
| US20060241038A1 (en) | 2005-04-20 | 2006-10-26 | Eisai Co., Ltd. | Therapeutic agent for Abeta related disorders |
| WO2007034282A2 (fr) | 2005-09-19 | 2007-03-29 | Pfizer Products Inc. | Composes de biphenylimidazole utilises comme antagonistes du recepteur du c3a |
| CA2628047A1 (fr) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | Procede de production d'un derive cinnamide |
| EP1953151A4 (fr) | 2005-11-18 | 2010-06-02 | Eisai R&D Man Co Ltd | Sels de composé cynamide ou solvates de ces derniers |
| US20070117839A1 (en) * | 2005-11-24 | 2007-05-24 | Eisai R&D Management Co., Ltd. | Two cyclic cinnamide compound |
| TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TWI386207B (zh) | 2005-11-24 | 2013-02-21 | Eisai R&D Man Co Ltd | 味啉類型之肉桂醯胺化合物 |
| TWI378091B (en) * | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| GEP20115139B (en) | 2006-03-09 | 2011-01-10 | Eisai R&D Man Co Ltd | Polycyclic cinnamide derivative |
| SA07280403B1 (ar) | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
| WO2008097538A1 (fr) | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Agents thérapeutiques |
| MX2009012177A (es) | 2007-05-07 | 2009-11-23 | Schering Corp | Moduladores de gamma-secretasa. |
| CN101675045B (zh) * | 2007-05-11 | 2012-11-28 | 弗·哈夫曼-拉罗切有限公司 | 作为β-淀粉样蛋白调节剂的杂芳基苯胺 |
| WO2008156580A1 (fr) | 2007-06-13 | 2008-12-24 | Merck & Co., Inc. | Dérivés du triazole destinés au traitement de la maladie d'alzheimer et d'états associés |
| CA2695543A1 (fr) | 2007-08-06 | 2009-02-12 | Schering Corporation | Modulateurs de la gamma-secretase |
-
2007
- 2007-07-25 SA SA7280403A patent/SA07280403B1/ar unknown
- 2007-07-25 US US11/878,556 patent/US7737141B2/en not_active Expired - Fee Related
- 2007-07-25 AR ARP070103296A patent/AR062095A1/es unknown
- 2007-07-26 EP EP07791337A patent/EP2048143A4/fr not_active Withdrawn
- 2007-07-26 MY MYPI20090056A patent/MY144971A/en unknown
- 2007-07-26 PE PE2007000966A patent/PE20080281A1/es not_active Application Discontinuation
- 2007-07-26 AU AU2007277729A patent/AU2007277729A1/en not_active Abandoned
- 2007-07-26 KR KR1020097004007A patent/KR20090033910A/ko not_active Withdrawn
- 2007-07-26 CA CA002658037A patent/CA2658037A1/fr not_active Abandoned
- 2007-07-26 JP JP2008526796A patent/JPWO2008013213A1/ja not_active Abandoned
- 2007-07-26 WO PCT/JP2007/064637 patent/WO2008013213A1/fr not_active Ceased
- 2007-07-26 EA EA200970172A patent/EA200970172A1/ru unknown
- 2007-07-26 TW TW096127264A patent/TW200821319A/zh unknown
- 2007-07-26 MX MX2008015504A patent/MX2008015504A/es not_active Application Discontinuation
- 2007-07-26 GE GEAP200711078A patent/GEP20115176B/en unknown
- 2007-07-26 NZ NZ574102A patent/NZ574102A/en not_active IP Right Cessation
-
2008
- 2008-12-11 CR CR10499A patent/CR10499A/es not_active Application Discontinuation
-
2009
- 2009-01-05 IL IL196351A patent/IL196351A0/en unknown
- 2009-01-06 CO CO09000699A patent/CO6150153A2/es unknown
- 2009-01-23 TN TN2009000024A patent/TN2009000024A1/fr unknown
- 2009-01-26 HN HN2009000157A patent/HN2009000157A/es unknown
- 2009-01-27 EC EC2009009091A patent/ECSP099091A/es unknown
- 2009-01-28 SV SV2009003157A patent/SV2009003157A/es unknown
- 2009-02-03 NO NO20090541A patent/NO20090541L/no not_active Application Discontinuation
- 2009-02-11 MA MA31628A patent/MA30636B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2008013213A1 (ja) | 2009-12-17 |
| ECSP099091A (es) | 2009-02-27 |
| CA2658037A1 (fr) | 2008-01-31 |
| NZ574102A (en) | 2010-10-29 |
| SA07280403B1 (ar) | 2010-12-01 |
| HN2009000157A (es) | 2011-01-24 |
| EP2048143A1 (fr) | 2009-04-15 |
| AU2007277729A1 (en) | 2008-01-31 |
| MA30636B1 (fr) | 2009-08-03 |
| AR062095A1 (es) | 2008-10-15 |
| PE20080281A1 (es) | 2008-05-05 |
| US20090048213A1 (en) | 2009-02-19 |
| CR10499A (es) | 2009-03-20 |
| EA200970172A1 (ru) | 2009-08-28 |
| SV2009003157A (es) | 2010-01-12 |
| US7737141B2 (en) | 2010-06-15 |
| KR20090033910A (ko) | 2009-04-06 |
| EP2048143A4 (fr) | 2010-11-03 |
| TN2009000024A1 (en) | 2010-08-19 |
| CO6150153A2 (es) | 2010-04-20 |
| WO2008013213A1 (fr) | 2008-01-31 |
| IL196351A0 (en) | 2009-09-22 |
| MY144971A (en) | 2011-11-30 |
| MX2008015504A (es) | 2008-12-18 |
| TW200821319A (en) | 2008-05-16 |
| GEP20115176B (en) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000024A1 (en) | Prodrug of cinnamide compound | |
| NO20070368L (no) | Virale polymeraseinhibitorer | |
| NO20084583L (no) | Makrosykliske kinase-inhibitorer | |
| NO20083717L (no) | Pyrrolotriazin-anilin prodrugforbindelser anvendbare som kinaseinhibitorer | |
| EA200801381A1 (ru) | Производные пиримидина | |
| NO20065578L (no) | Substituerte metylaryl eller heteroarylamidforbindelser | |
| NO20065573L (no) | Orto-substituerte aryl eller heteroarylamidforbindelser | |
| DE602006019788D1 (de) | Oximester-Fotoinitiatoren | |
| NO20083390L (no) | Piperaziner og piperidiner som mGluR5-forsterkere | |
| WO2008108380A3 (fr) | Composés de pyrrole | |
| CR9830A (es) | Compuestos de amino-5-[4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de la b-secretasa | |
| WO2006133147A3 (fr) | Composes organiques | |
| EP2133330A4 (fr) | Atropisomère de dérivé de pyrrole | |
| AU2008303600A8 (en) | 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives | |
| NO20082116L (no) | Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse | |
| EA017861B9 (ru) | Способ получения 4-оксохинолинового соединения | |
| WO2009054439A1 (fr) | Inhibiteur de la production de pai-1 | |
| WO2008126804A1 (fr) | Composition destinée à former un film sous résist | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| NO20071012L (no) | Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat | |
| ATE501103T1 (de) | Organische verbindungen | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| WO2008033757A3 (fr) | Dérivés d'acétamide 2-(1-oxo-1h-isoquinolin-2-yl) | |
| ATE519818T1 (de) | Reversibel thermochrome zusammensetzung | |
| NO20051089L (no) | Bredspektrede 2-amino-benzotiazol-sulfonamid-HIV-proteaseinhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |